The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

We’ll See What VC

A post on Capital Rants this morning says the Mayfield Fund will be the Ontario Venture Capital Fund’s first investment, that it will be in the range of US$5 – US$7.5 million, and that Mayfield will open a one-person office in Toronto.  Mayfield’s investments page shows they invested in biotech and device plays in the past: Amgen, Genentech, Heartstream, Immunex, Intuitive Surgical, Millennium Pharmaceuticals, Orquest, Radiant Research, Sunesis Pharmaceuticals, Tularik, Velocity11 (and one cleantech company: PolyFuel). 

However, the list is sortable by categories, all of which are IT focused, and tech investments account for 145 out of the 158 listed investments.  As they say, though, past performance does not guarantee future results, so we’ll see what Mayfield does in Canada.

If Mayfield wants a glimpse at some of the Toronto community, they could check out the Entrepreneurship 101 lectures, which have recently included conversations about venture capital from the VC side and from the company side.

There’s also the recent CVCA Report (pdf), and a summary post at Capital Rants.

Bookmark and Share

About these ads

One response to “We’ll See What VC

  1. Pingback: OVCF Scoreboard: Commitments 1, Biotech/Cleantech 0 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 130 other followers